These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28871426)

  • 1. Assessment of overactive bladder symptoms among women with successful pessary placement.
    Zacharakis D; Grigoriadis T; Pitsouni E; Kypriotis K; Vogiatzis N; Athanasiou S
    Int Urogynecol J; 2018 Apr; 29(4):571-577. PubMed ID: 28871426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study).
    Herschorn S; Chapple CR; Abrams P; Arlandis S; Mitcheson D; Lee KS; Ridder A; Stoelzel M; Paireddy A; van Maanen R; Robinson D
    BJU Int; 2017 Oct; 120(4):562-575. PubMed ID: 28418102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic organ prolapse and overactive bladder.
    de Boer TA; Salvatore S; Cardozo L; Chapple C; Kelleher C; van Kerrebroeck P; Kirby MG; Koelbl H; Espuna-Pons M; Milsom I; Tubaro A; Wagg A; Vierhout ME
    Neurourol Urodyn; 2010; 29(1):30-9. PubMed ID: 20025017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective comparison of ring pessary and multicomponent behavioral therapy in managing overactive bladder.
    Sze EH; Hobbs G
    Int Urogynecol J; 2014 Nov; 25(11):1583-8. PubMed ID: 24803217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Prolapse and Urinary Symptoms After Successful Fitting of a Ring Pessary With Support in Women With Advanced Pelvic Organ Prolapse: A Prospective Study.
    Ding J; Chen C; Song XC; Zhang L; Deng M; Zhu L
    Urology; 2016 Jan; 87():70-5. PubMed ID: 26375847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the symptoms and quality of life of women with symptomatic pelvic organ prolapse fitted with a ring with support pessary.
    Mao M; Ai F; Zhang Y; Kang J; Liang S; Xu T; Zhu L
    Maturitas; 2018 Nov; 117():51-56. PubMed ID: 30314561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse.
    Mao M; Ai F; Kang J; Zhang Y; Liang S; Zhou Y; Zhu L
    Menopause; 2019 Feb; 26(2):145-151. PubMed ID: 30130292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Overactive Bladder in the Face of High Grade Prolapse.
    Guzman-Negron J; Vasavada S
    Curr Urol Rep; 2017 Feb; 18(2):12. PubMed ID: 28213857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
    Dokmeci F; Cetinkaya SE; Seval MM; Dai O
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
    Ginsberg D; Schneider T; Kelleher C; Van Kerrebroeck P; Swift S; Creanga D; Martire DL
    BJU Int; 2013 Aug; 112(3):373-85. PubMed ID: 23826844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with pessary fitting in women with symptomatic pelvic organ prolapse: A large prospective cohort study.
    Ma C; Xu T; Kang J; Zhang Y; Ma Y; Liang S; Zhu L
    Neurourol Urodyn; 2020 Nov; 39(8):2238-2245. PubMed ID: 32936968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of mesh pelvic floor reconstructive surgery on OAB symptoms].
    Nowakowski L; Wróbel A; Jankiewicz K; Kulik-Rechberger B; Rechberger T
    Ginekol Pol; 2014 Oct; 85(10):760-4. PubMed ID: 25546927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-neurological overactive bladder and pelvic-perineal pathology in women].
    Gamé X; Phé V
    Prog Urol; 2020 Nov; 30(14):887-894. PubMed ID: 33220817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How does site of pelvic organ prolapse repair affect overactive bladder symptoms?
    Dieter AA; Edenfield AL; Weidner AC; Siddiqui NY
    Female Pelvic Med Reconstr Surg; 2014; 20(4):203-7. PubMed ID: 24978085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year prospective comparison of vaginal pessaries and surgery for pelvic organ prolapse using the validated ICIQ-VS and ICIQ-UI (SF) questionnaires.
    Lone F; Thakar R; Sultan AH
    Int Urogynecol J; 2015 Sep; 26(9):1305-12. PubMed ID: 25862241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of lower urinary tract symptoms in treatment-seeking women with pelvic organ prolapse; the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN).
    Kowalski JT; Wiseman JB; Smith AR; Helmuth ME; Cameron A; DeLancey JOL; Hendrickson WK; Jelovsek JE; Kirby A; Kreder K; Lai HH; Mueller M; Siddiqui N; Bradley CS
    Am J Obstet Gynecol; 2022 Dec; 227(6):875.e1-875.e12. PubMed ID: 35934118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Primary Endpoint for Exploratory Clinical Trial in Patients with Overactive Bladder: A Systematic Literature Review.
    Iino S; Kaneko M; Narukawa M
    Low Urin Tract Symptoms; 2018 Jan; 10(1):64-75. PubMed ID: 27792298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact on quality of life after ring pessary use for pelvic organ prolapse.
    Manchana T; Bunyavejchevin S
    Int Urogynecol J; 2012 Jul; 23(7):873-7. PubMed ID: 22222673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can botox improve night-time overactive bladder symptoms in women?
    Miotla P; Cartwright R; Futyma K; Bogusiewicz M; Skorupska K; Winkler I; Rechberger T
    Neurourol Urodyn; 2017 Mar; 36(3):648-652. PubMed ID: 26915654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.
    Herschorn S; Barkin J; Castro-Diaz D; Frankel JM; Espuna-Pons M; Gousse AE; Stölzel M; Martin N; Gunther A; Van Kerrebroeck P
    Urology; 2013 Aug; 82(2):313-20. PubMed ID: 23769122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.